Nanostrategies to Develop Current Antiviral Vaccines.
ACS Appl Bio Mater
; 4(5): 3880-3890, 2021 05 17.
Article
en En
| MEDLINE
| ID: mdl-35006813
ABSTRACT
Infectious diseases are a worldwide concern. They are responsible for increasing the mortality rate and causing economic and social problems. Viral epidemics and pandemics, such as the COVID-19 pandemic, force the scientific community to consider molecules with antiviral activity. A number of viral infections still do not have a vaccine or efficient treatment and it is imperative to search for vaccines to control these infections. In this context, nanotechnology in association with the design of vaccines has presented an option for virus control. Nanovaccines have displayed an impressive immune response using a low dosage. This review aims to describe the advances and update the data in studies using nanovaccines and their immunomodulatory effect against human viruses.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Virosis
/
Vacunas Virales
/
Nanomedicina
/
Desarrollo de Vacunas
Límite:
Humans
Idioma:
En
Revista:
ACS Appl Bio Mater
Año:
2021
Tipo del documento:
Article
País de afiliación:
Brasil